Drug Delivery · 2021 · 38 citations · 54 references
PharmacyPharmaceuticsPharmacologyBioavailabilityDrug DeliveryNanoparticle Drug DeliveryDrug Delivery BiomaterialsNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicineNanoparticle DesignOtotoxicityControlled Drug ReleaseDrug Delivery NanocarriersLocal Drug DeliveryLocal Drug Delivery SystemsNanocarrier CharacterizationNanoparticle Drug Delivery SystemsPoly(lactic-co-glycolic Acid)Poly(lactic-co-glycolic Acid) Nanoparticles
drug release was studied using a Franz diffusion cell. Cytotoxicity of the formulations was investigated using SK-MEL-31 cells. Inflammatory responses were evaluated by histological observation of spiral ganglion cells and stria vascularis in the mouse cochlea 24 h after IT administration. In addition, the biodistribution of the formulations in mouse ears was observed by fluorescence imaging using coumarin-6. DEX-NPs showed a particle size of 150.0 ± 3.2 nm in diameter and a zeta potential of -18.7 ± 0.6. The DEX-NP-gel showed a gelation time of approximately 64 s at 37 °C and presented a similar release profile and cytotoxicity as that for DEX-NP. Furthermore, no significant inflammatory response was observed after IT administration. Fluorescence imaging results suggested that DEX-NP-gel sustained release compared to the other formulations. In conclusion, the PLGA NP-loaded thermosensitive gel may be a potential drug delivery system for the inner ear.
54
Enas Elmowafy, Mattia Tiboni, Mahmoud E. Soliman · Journal of Pharmaceutical Investigation · 2019 · 610 citations
Natural Sciences, Bioengineering, Biomedical Engineering +16